Skip to main content
. 2022 Apr 8;114(7):969–978. doi: 10.1093/jnci/djac071

Table 4.

Complication rate sorted by location of the primary tumora

Complications ≤30 d
31–90 d
91–180 d
0–180 d
CD I-CD II CD III-CD IV CD I-CD II CD III-CD IV CD I-CD II CD III-CD IV CD I-CD II CD III-CD IV
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Upper GI (n = 106) 29 (27.4) 18 (17.0) 20 (18.9) 7 (6.6) 15 (14.2) 8 (7.5) 32 (30.2) 23 (21.7)
Lower GI (n = 633) 152 (24.0) 77 (12.1) 94 (14.8) 36 (5.6) 105 (16.6) 30 (4.7) 210 (33.2) 112 (17.6)
HPB (n = 105) 32 (30.5) 21 (20.0) 13 (12.4) 12 (11.4) 14 (13.3) 10 (9.5) 38 (36.2) 26 (24.8)
Thoracic (n = 36) 18 (50.0) 3 (8.3) 12 (33.3) 4 (11.1) 12 (33.3) 2 (5.6) 21 (58.3) 4 (8.3)
Others (n = 68) 11 (16.2) 9 (13.2) 8 (11.8) 6 (8.8) 11 (16.2) 2 (2.9) 15 (22.1) 12 (17.6)
a

CD = Clavien-Dindo classification complication grade; GI = gastrointestinal; HBP = pancreas, duodenum, liver, biliary tree.